COVID-19

On this episode of CHPA Chat, we're talking about the explosion in digital health. Not just the watch you may be wearing, but technology that could enable healthcare, and very importantly self-care. Today, we're talking about digital health, what it means for the industry, and what the future holds for this rapidly growing sector.

In today's episode, we're discussing a topic that doesn't often get the attention it needs — sexual health. Join Anita Brikman and Bruce Weiss as they explore the state of sexual health in the US today and the role that OTC sexual health products play.

On this episode of CHPA Chat, we're talking about the booming business of dietary supplements, especially as a result of the COVID-19 pandemic. But class action lawsuits are also on the rise. In today's episode, we're discussing this real risk to companies and what they can do to get ready.

We don't often think about insurance coverage for OTC medicines, but more and more health plans are offering this benefit. In this episode, we'll explore what new research is telling us about this and why Medicare Advantage is a big opportunity for self-care.

CHPA's Self-Care Leadership Summit (SLS) is the intimate, exclusive gathering of consumer healthcare industry leaders. Don't miss this exclusive sneak peek of the meeting!

The Senate HELP Committee will vote next Wednesday, January, 12, on whether to send Dr. Robert Califf’s nomination as FDA commissioner to the Senate floor for a confirmation vote.

Join Wayfair’s Head of Product Development, Matt Phillips and John Troup to explore consumer engagement and how dietary supplements companies can help provide online services that build brand loyalty and keep people coming back.

As healthcare transitions from a delivery to ‘self-owned’ care model, effective solutions that engage consumers are needed. During this episode, John Troup and Jenna Philips share the latest insights on the world of digital platforms and how they influence consumer engagement.

ACI and CHPA praise FDA for announcing the withdrawal of its temporary guidance for the manufacturing of alcohol-based hand sanitizer products.